Article: Serotonin uptake by blood platelets of acute schizophrenic patients

Active uptake of serotonin by blood platelets of acute schizophrenic patients has been compared to that of a control group. Preliminary results presented in this article indicate that the uptake of the schizophrenic patients was about 40% lower than that of controls. Patients were followed over a period of 5 weeks with no significant change in uptake.

Citing Articles

The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Ohuoha D, Hyde T, Kleinman J Psychopharmacology (Berl). 1993; 112(1 Suppl):S5-15.

PMID: 7831440 DOI: 10.1007/BF02245003.

The active uptake of serotonin by platelets of schizophrenic patients and their families: possibility of a genetic marker.

Rotman A, Zemishlany Z, Munitz H, WIJSENBEEK H Psychopharmacology (Berl). 1982; 77(2):171-4.

PMID: 6812135 DOI: 10.1007/BF00431943.

Molecular aspects of the imipramine 'receptor'.

Davis A Experientia. 1984; 40(8):783-94.

PMID: 6088274 DOI: 10.1007/BF01951960.

Platelet [3H]imipramine binding in autism and schizophrenia.

Weizman A, Gonen N, Tyano S, Szekely G, Rehavi M Psychopharmacology (Berl). 1987; 91(1):101-3.

PMID: 3103151 DOI: 10.1007/BF00690935.

Platelet research in psychiatry.

Wirz-Justice A Experientia. 1988; 44(2):145-52.

PMID: 2831076 DOI: 10.1007/BF01952199.

References

1.

Murphy D, Wyatt R . Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature. 1972; 238(5361):225-6. DOI: 10.1038/238225a0. View

2.

WISE C, Stein L . Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients. Science. 1973; 181(4097):344-7. DOI: 10.1126/science.181.4097.344. View

3.

Gillin J, Kaplan J, Stillman R, Wyatt R . The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine. Am J Psychiatry. 1976; 133(2):203-8. DOI: 10.1176/ajp.133.2.203. View

4.

Saavedra J, Coyle J, Axelrod J . The distribution and properties of the nonspecific N-methyltransferase in brain. J Neurochem. 1973; 20(3):743-52. DOI: 10.1111/j.1471-4159.1973.tb00035.x. View

5.

Banerjee S, Snyder S . Methyltetrahydrofolic acid mediates N- and O-methylation of biogenic amines. Science. 1973; 182(4107):74-5. DOI: 10.1126/science.182.4107.74. View

6.

Schneider K . [Primary & secondary symptoms in schizophrenia]. Fortschr Neurol Psychiatr Grenzgeb. 1957; 25(9):487-90. View

7.

Sneddon J . Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol. 1973; 1(2):151-98. DOI: 10.1016/0301-0082(73)90019-1. View

8.

Garelis E, Gillin J, Wyatt R, NEFF N . Elevated blood serotonin concentrations in unmediated chronic schizophrenic patients: a preliminary study. Am J Psychiatry. 1975; 132(2):184-6. DOI: 10.1176/ajp.132.2.184. View

9.

Axelrod J . The enzymatic N-methylation of serotonin and other amines. J Pharmacol Exp Ther. 1962; 138:28-33. View

10.

Saavedra J, Axelrod J . Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro. Science. 1972; 175(4028):1365-6. DOI: 10.1126/science.175.4028.1365. View

11.

Meltzer H, Stahl S . Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. Res Commun Chem Pathol Pharmacol. 1974; 7(2):419-31. View

12.

Morgan M, Mandell A . Indole(ethyl)amine N-methyltransferase in the brain. Science. 1969; 165(3892):492-3. DOI: 10.1126/science.165.3892.492. View

13.

Snyder S . The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry. 1976; 133(2):197-202. DOI: 10.1176/ajp.133.2.197. View

Serotonin Uptake by Blood Platelets of Acute Schizophrenic Patients